Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly (original) (raw)

The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome

American Journal of Obstetrics and Gynecology, 1994

Down syndrome screening marker levels in women with a previous aneuploidy pregnancy

Prenatal Diagnosis, 2005

Risk of Down syndrome and any clinically significant chromosome defect in pregnancies with abnormal triple-screen and normal targeted ultrasonographic results

Ray Bahado-singh

American Journal of Obstetrics and Gynecology, 1996

View PDFchevron_right

The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester

Bryann Bromley

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2002

View PDFchevron_right

One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester

Kevin Spencer

BJOG: An International Journal of Obstetrics and Gynaecology, 2000

View PDFchevron_right

Significance of Low Maternal Serum Β-hCG Levels in the Assessment of the Risk of Atypical Chromosomal Abnormalities

Antoni Borrell

Fetal Diagnosis and Therapy, 2021

View PDFchevron_right

Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011

Peter Benn

Prenatal Diagnosis, 2011

View PDFchevron_right

Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population

Greg Kesby

Australian & New Zealand Journal of Obstetrics & Gynaecology, 2004

View PDFchevron_right

PRENATAL SCREENING FOR FETAL ANEUPLOIDY, DOWN’S SYNDROME, WHO, WHOM, WHY & HOW?????

IP Innovative Publication Pvt. Ltd.

View PDFchevron_right

A prospective trial of prenatal screening for Down syndrome by means of maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol

Gail Prins

American Journal of Obstetrics and Gynecology, 1993

View PDFchevron_right

Isolated Sonographic Markers for Detection of Fetal Down Syndrome in the Second Trimester of Pregnancy

scott young

2001

View PDFchevron_right

Incidental Finding of Ultrasound Markers for Down Syndrome in the Second Trimester of Pregnancy: A Case Study

Marcia Van Riper

Journal of Midwifery & Women's Health, 2005

View PDFchevron_right

Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women

Karin Sundberg

Ultrasound in Obstetrics and Gynecology, 2005

View PDFchevron_right

Triple marker study in midtrimester of pregnancy and risk of chromosomal abnormality

Nrupesh Oza

medind.nic.in

View PDFchevron_right

First trimester ultrasound screening of chromosomal abnormalities

Aleksandra Trninić Pjević

Srpski arhiv za celokupno lekarstvo, 2007

View PDFchevron_right

Ultrasonographic Findings of Fetal Aneuploidies in the Second Trimester – Our Experiences

Csaba Pap

Fetal Diagnosis and Therapy, 2007

View PDFchevron_right

The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity

snježana škrablin

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2000

View PDFchevron_right

Sonographically determined anomalies and outcome in 170 chromosomally abnormal fetuses

Titia Cohen-overbeek

Prenatal Diagnosis, 1995

View PDFchevron_right

PRENATAL DIAGNOSIS OF CHROMOSOME ABNORMALITIES

Monica Echevarria

Acta Paediatrica, 1972

View PDFchevron_right

eta-analysis of first trimester Down syndrome screening tudies: free -human chorionic gonadotropin significantly utperforms intact human chorionic gonadotropin in a ultimarker protocol

Robert Galen

2007

View PDFchevron_right

Screening for fetal chromosomal abnormalities by maternal serum biochemistry and ultrasound examination of fetal morphology

Recep Has

Current Opinion in Obstetrics and Gynecology, 1993

View PDFchevron_right

Prenatal screening for Down syndrome: should first trimester ultrasound replace maternal serum screening?

Jean-françois Oury

Early Human Development, 1996

View PDFchevron_right

Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis

Antoni Borrell, Jo-Ann Johnson, Peter Benn

Prenatal diagnosis, 2015

View PDFchevron_right

Ultrasonographic screening for the Down syndrome fetus

Charles J Lockwood

American Journal of Obstetrics and Gynecology, 1991

View PDFchevron_right

Urine hyperglycosylated hCG plus ultrasound biometry for detection of Down syndrome in the second trimester in a high-risk population

Laurence Cole

Obstetrics & Gynecology, 2000

View PDFchevron_right

Ultrasound screening for chromosomal abnormalities in the second trimester

Mohamed Abdalla

The Obstetrician & Gynaecologist, 2001

View PDFchevron_right

First trimester combined screening for fetal aneuploidies enhanced with additional ultrasound markers: an 8-year prospective study

Alexandra Cristofor

Ginekologia Polska, 2018

View PDFchevron_right

Detection of hydatidiform mole in maternal serum screening programmes for Down's syndrome

James Densem

BJOG: An International Journal of Obstetrics and Gynaecology, 1992

View PDFchevron_right

Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay

Kevin Spencer

Prenatal Diagnosis, 2003

View PDFchevron_right

Correlation of Second-Trimester Sonographic and Biochemical Markers

Peter Benn

Journal of Ultrasound in Medicine, 2004

View PDFchevron_right

The Reliability of Maternal Serum Triple Test in Prenatal Diagnosis of Fetal Chromosomal Abnormalities of Pregnant Turkish Women

Osman Demirhan

Genetic Testing and Molecular Biomarkers, 2011

View PDFchevron_right

Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies

OMKAR SINGH

American Journal of Obstetrics and Gynecology, 2000

View PDFchevron_right

Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly (original) (raw)

Related papers